Anti-Tau Antibody Semorinemab Fails to Slow Alzheimer Disease

JAMA. 2022 Aug 2;328(5):415. doi: 10.1001/jama.2022.12727.
No abstract available

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / immunology
  • Antibodies, Monoclonal* / immunology
  • Antibodies, Monoclonal* / therapeutic use
  • Brain / drug effects
  • Brain / immunology
  • Humans
  • Neuroprotective Agents* / immunology
  • Neuroprotective Agents* / therapeutic use
  • tau Proteins* / antagonists & inhibitors
  • tau Proteins* / immunology

Substances

  • Antibodies, Monoclonal
  • Neuroprotective Agents
  • tau Proteins